These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

489 related items for PubMed ID: 27888981

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Emerging role of immunotherapy in urothelial carcinoma-Future directions and novel therapies.
    Park JC, Hahn NM.
    Urol Oncol; 2016 Dec; 34(12):566-576. PubMed ID: 27773553
    [Abstract] [Full Text] [Related]

  • 5. Making urothelial carcinomas less immune to immunotherapy.
    Ramos JD, Yu EY.
    Urol Oncol; 2016 Dec; 34(12):534-537. PubMed ID: 27836245
    [Abstract] [Full Text] [Related]

  • 6. The next generation of immunotherapy: keeping lung cancer in check.
    Somasundaram A, Burns TF.
    J Hematol Oncol; 2017 Apr 24; 10(1):87. PubMed ID: 28434399
    [Abstract] [Full Text] [Related]

  • 7. Immunotherapy for Urothelial Carcinoma: Current Evidence and Future Directions.
    Tripathi A, Plimack ER.
    Curr Urol Rep; 2018 Nov 07; 19(12):109. PubMed ID: 30406502
    [Abstract] [Full Text] [Related]

  • 8. Emerging Role of Immunotherapy in Advanced Urothelial Carcinoma.
    Koshkin VS, Grivas P.
    Curr Oncol Rep; 2018 Apr 11; 20(6):48. PubMed ID: 29644490
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [First-line treatment of metastatic urothelial carcinoma : Update immuno-oncology].
    Zacharis A, Grüllich C.
    Urologe A; 2020 Jul 11; 59(7):797-803. PubMed ID: 32500171
    [Abstract] [Full Text] [Related]

  • 13. Immunotherapy in metastatic urothelial carcinoma: focus on immune checkpoint inhibition.
    Siefker-Radtke A, Curti B.
    Nat Rev Urol; 2018 Feb 11; 15(2):112-124. PubMed ID: 29205200
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The benefits of immunotherapy combinations.
    Schmidt C.
    Nature; 2017 Dec 21; 552(7685):S67-S69. PubMed ID: 29293245
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. #Checkmate: could checkpoint inhibitors be the game changer in the fight against metastatic urothelial carcinoma?
    Dhariwal R, Pindoria N, Dasgupta P, Khan MS.
    BJU Int; 2019 Feb 21; 123(2):203-207. PubMed ID: 29974606
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.